Esoflam Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg, Paracetamol 325 mg, and Serratiopeptidase 10 mg. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), provides potent anti-inflammatory and analgesic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol acts as an analgesic and antipyretic, offering effective pain relief and fever reduction through central inhibition of prostaglandin synthesis. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and inflammation. This combination is indicated for the management of acute and chronic painful conditions such as musculoskeletal disorders, postoperative pain, dental pain, and inflammatory conditions. Esoflam Tablet is particularly beneficial in reducing pain, swelling, and inflammation simultaneously, improving patient comfort and mobility. It should be used under medical supervision, especially in patients with a history of gastrointestinal ulcers, hepatic or renal impairment, or hypersensitivity to NSAIDs. Common side effects may include gastrointestinal discomfort, nausea, and allergic reactions. Caution is advised in patients on anticoagulants or with bleeding disorders. Overall, Esoflam Tablet offers a synergistic approach to pain and inflammation management, enhancing therapeutic outcomes in various clinical scenarios.